Significant neuropsychiatric symptoms: three mucopolysaccharidosis type IIIB cases, two of whom were siblings with a novel NAGLU gene mutation
暂无分享,去创建一个
[1] D. Grinberg,et al. Sanfilippo Syndrome: Molecular Basis, Disease Models and Therapeutic Approaches , 2020, International journal of molecular sciences.
[2] Lidia Gaffke,et al. Genetic Base of Behavioral Disorders in Mucopolysaccharidoses: Transcriptomic Studies , 2020, International journal of molecular sciences.
[3] W. Hwu,et al. Mucopolysaccharidosis III in Taiwan: Natural history, clinical and molecular characteristics of 28 patients diagnosed during a 21‐year period , 2018, American journal of medical genetics. Part A.
[4] C. Siffel,et al. Epidemiology of Sanfilippo syndrome: results of a systematic literature review , 2018, Orphanet Journal of Rare Diseases.
[5] Yuwu Jiang,et al. Mucopolysaccharidosis IIIB and mild skeletal anomalies: coexistence of NAGLU and CYP26B1 missense variations in the same patient in a Chinese family , 2018, BMC Medical Genetics.
[6] R. Crystal,et al. Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1/2 clinical trial , 2017, The Lancet Neurology.
[7] A. Wittkowski,et al. Symptoms of Autism Spectrum Disorder (ASD) in Individuals with Mucopolysaccharide Disease Type III (Sanfilippo Syndrome): A Systematic Review , 2017, Journal of Autism and Developmental Disorders.
[8] K. Flanigan,et al. A prospective one-year natural history study of mucopolysaccharidosis types IIIA and IIIB: Implications for clinical trial design. , 2016, Molecular genetics and metabolism.
[9] Raymond M. Moore,et al. Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer. , 2016, American journal of human genetics.
[10] A. Fedele,et al. The Application of Clinical Genetics Dovepress Sanfilippo Syndrome: Causes, Consequences, and Treatments , 2022 .
[11] L. Gort,et al. Natural history of Sanfilippo syndrome in Spain , 2013, Orphanet Journal of Rare Diseases.
[12] T. Shimada,et al. Newborn screening and diagnosis of mucopolysaccharidoses. , 2013, Molecular genetics and metabolism.
[13] B. Burton,et al. Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit/hyperactivity disorder or autism spectrum disorder , 2013, Acta paediatrica.
[14] D. Zafeiriou,et al. Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece , 2011, American journal of medical genetics. Part A.
[15] R. Wevers,et al. Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype , 2010, Journal of Inherited Metabolic Disease.
[16] U. Moog,et al. Is Sanfilippo type B in your mind when you see adults with mental retardation and behavioral problems? , 2007, American journal of medical genetics. Part C, Seminars in medical genetics.
[17] R. Taherian,et al. An Uncommon Presentation of Mucopolysaccharidosis Type IIIb , 2019, Iranian journal of child neurology.
[18] A. Shaywitz,et al. Design and rationale of ongoing observational and treatment studies for BMN 250: a novel enzyme replacement therapy for Sanfilippo syndrome type B , 2017 .
[19] B. Poorthuis,et al. Sanfilippo syndrome: A mini-review , 2008, Journal of Inherited Metabolic Disease.